About: Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. Goto Sponge NotDistinct Permalink

An Entity of Type : http://wikiba.se/ontology#Item, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Item
label	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
preferred label	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
described by	https://covidontheweb.inria.fr:4443/about/id/entity/http/www.wikidata.org/entity/Q37378403
schema:name	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
schema:description	scientific article published on 18 May 2009
is topic of	Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
is wdt:P2860 of	Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
is http://www.wikidat...p/statement/P2860 of	wd:statement/Q37378403-556F311B-00F7-4153-B6A5-AE8C0460F7DF

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software